Sunday - June 2, 2024

Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate

2024-03-26

ALEXANDRIA, Virginia, March 26 -- SLAYBACK PHARMA LLC, Princeton, New Jersey has been assigned a patent (No. US 11938217 B2, initially filed Jan. 18, 2023) developed by five inventors Rahul Dhulaji Bhise, Hyderabad, India; Ajay Kumar Singh, Princeton, New Jersey; Mahadeo Vasant Mahadik, Hyderabad, India; Ashish Anilrao Dubewar, Hyderabad, India; and Molugu Prashanth Reddy, Hyderabad, India, for "Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate

Information Request Form

Copyright Targeted News Service 2024